[MO44] Mini-Oral Session 44　Lung Cancer / Thoracic Cancer 7（ICI）
【E】

[MO44-2] Efficacy and Safety of Immune checkpoint inhibitors in elderly patients with NSCLC in the real-world (HOT1902)

^○Hisashi Tanaka¹, Shotaro Ito², Hajime Asahina², Osamu Honjo³, Ryoichi Honda⁴, Satoshi Oizumi⁵, Keiichi Nakamura⁶, Kei Takamura⁷, Fumihiro Hommura⁸, Yasutaka Kawai⁹, Kenichiro Ito¹⁰, Noriaki Sukoh¹¹, Keiki Yokoo¹², Ryo Morita¹³, Toshiyuki Harada¹⁴, Taichi Takashina¹⁵, Tomohiro Goda¹⁶, Hirotoshi Dosaka-Akita¹⁶, Hiroshi Isobe¹⁰ (1.Department of Respiratory Medicine, Hirosaki University, Graduate School of Medicine, 2.Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, 3.Department of Respiratory Medicine, Sapporo Minami-Sanjo Hospital, 4.Department of Respiratory Medicine, Asahi General Hospital, 5.Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan, 6.Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, 7.Department of Respiratory Medicine, Obihiro-Kosei General Hospital, 8.Department of Respiratory Medicine, Sapporo City General Hospital, 9.Department of Respiratory Medicine, Oji General Hospital, 10.Department of Respiratory Medicine, KKR Sapporo Medical Center, 11.Department of Respiratory Medicine, National Hospital Organization Hokkaido Medical Center, 12.Department of Respiratory Medicine, Teine Keijinkai Hospital, 13.Department of Respiratory Medicine, Akita Kousei Medical Center, 14.Department of Respiratory Medicine, JCHO Hokkaido Hospital, 15.Department of Respiratory Medicine, Iwamizawa Municipal General Hospital, 16.Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University)